Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 2 | 2017 | 702 | 0.640 |
Why?
|
| Health Plan Implementation | 1 | 2016 | 40 | 0.490 |
Why?
|
| Pneumothorax | 2 | 2013 | 49 | 0.490 |
Why?
|
| Terminal Care | 1 | 2017 | 119 | 0.490 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 184 | 0.460 |
Why?
|
| Pulmonary Medicine | 2 | 2020 | 41 | 0.420 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2013 | 13 | 0.400 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 42 | 0.400 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 325 | 0.390 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 84 | 0.380 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 136 | 0.380 |
Why?
|
| Internal Medicine | 1 | 2013 | 154 | 0.370 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 431 | 0.370 |
Why?
|
| Fellowships and Scholarships | 1 | 2013 | 102 | 0.370 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 134 | 0.360 |
Why?
|
| Colitis, Ulcerative | 2 | 2009 | 76 | 0.350 |
Why?
|
| Clinical Competence | 2 | 2013 | 726 | 0.350 |
Why?
|
| Mass Screening | 1 | 2016 | 698 | 0.330 |
Why?
|
| Patient Safety | 1 | 2013 | 259 | 0.330 |
Why?
|
| Women's Health | 1 | 2013 | 374 | 0.320 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 347 | 0.320 |
Why?
|
| Veterans | 1 | 2017 | 761 | 0.310 |
Why?
|
| Capsule Endoscopes | 1 | 2009 | 4 | 0.300 |
Why?
|
| Critical Care | 1 | 2013 | 402 | 0.300 |
Why?
|
| Quality of Health Care | 1 | 2013 | 528 | 0.300 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 40 | 0.290 |
Why?
|
| Intestine, Small | 1 | 2009 | 82 | 0.290 |
Why?
|
| Crohn Disease | 1 | 2009 | 106 | 0.270 |
Why?
|
| Lung | 1 | 2012 | 966 | 0.260 |
Why?
|
| Internship and Residency | 1 | 2013 | 800 | 0.240 |
Why?
|
| Cohort Studies | 4 | 2013 | 2620 | 0.190 |
Why?
|
| Tracheomalacia | 1 | 2021 | 5 | 0.170 |
Why?
|
| Trachea | 1 | 2021 | 83 | 0.160 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2021 | 39 | 0.160 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2020 | 14 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2017 | 6872 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2020 | 157 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2020 | 177 | 0.140 |
Why?
|
| United States | 3 | 2017 | 8093 | 0.140 |
Why?
|
| Humans | 11 | 2021 | 65140 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 138 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2701 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 202 | 0.130 |
Why?
|
| Sarcoidosis | 2 | 2020 | 34 | 0.130 |
Why?
|
| Bronchoscopy | 2 | 2020 | 88 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2757 | 0.130 |
Why?
|
| Pulmonologists | 1 | 2016 | 5 | 0.120 |
Why?
|
| Middle Aged | 5 | 2017 | 18273 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 544 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2483 | 0.120 |
Why?
|
| Veterans Health | 1 | 2016 | 145 | 0.110 |
Why?
|
| Registries | 1 | 2017 | 924 | 0.100 |
Why?
|
| Female | 6 | 2021 | 34018 | 0.100 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 57 | 0.100 |
Why?
|
| Medicare | 1 | 2017 | 625 | 0.100 |
Why?
|
| Male | 5 | 2017 | 31047 | 0.100 |
Why?
|
| Accreditation | 1 | 2013 | 76 | 0.100 |
Why?
|
| Risk Factors | 2 | 2013 | 5429 | 0.090 |
Why?
|
| Florida | 1 | 2012 | 46 | 0.090 |
Why?
|
| Aged | 3 | 2021 | 14965 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2012 | 286 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2013 | 393 | 0.080 |
Why?
|
| Mesalamine | 1 | 2009 | 4 | 0.080 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 17 | 0.080 |
Why?
|
| Curriculum | 1 | 2013 | 608 | 0.070 |
Why?
|
| Probability | 1 | 2009 | 170 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1698 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2009 | 252 | 0.070 |
Why?
|
| Biopsy | 2 | 2021 | 456 | 0.070 |
Why?
|
| Age Distribution | 1 | 2009 | 262 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 1656 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2013 | 3308 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2009 | 199 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5614 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 991 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1163 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1113 | 0.060 |
Why?
|
| Adult | 3 | 2013 | 17358 | 0.060 |
Why?
|
| Incidence | 1 | 2009 | 1419 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 2102 | 0.050 |
Why?
|
| Mouth | 1 | 2021 | 36 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2020 | 12 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 35 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 46 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 46 | 0.040 |
Why?
|
| Endosonography | 1 | 2020 | 27 | 0.040 |
Why?
|
| Mediastinum | 1 | 2020 | 28 | 0.040 |
Why?
|
| Lymphadenopathy | 1 | 2020 | 23 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 45 | 0.040 |
Why?
|
| Eye Diseases | 1 | 2020 | 37 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 135 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 233 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 99 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 232 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 139 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 399 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 554 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 510 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 584 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2244 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 391 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1559 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 1260 | 0.010 |
Why?
|